Discovery of a pro-tumor effect of CAFs due to BCL9 depletionInhibition of abnormal activation of Wnt/β-catenin signal through BCL9 depletion benefits T-cell–mediated antitumor immune responses. The gene discussed is BCL9; the disease is neoplasm.